64-x is a biotechnology company that is headquartered in Cambridge, Massachusetts that was founded by Alexis Rovner, George Church, Jeffrey Way, and Pamela Silver in 2017. The company is using synthetic biology and genetic engineering to create microbes capable of performing economically valuable functions such as manufacturing a desired compound (biomanufacturing), removing/adding specific compounds to or from the organisms surrounding environment (bioremediation), or performing functions that improve human health.
The company has developed a platform that is capable of designing and conducting experiments on microorganisms in order to perform specific functions. They are able to make organism operate within foreign and otherwise dangerous or deadly environments, and to carry out new functions once there. This allows them to produce proteins and sequence-defined polymers. 64-x works with microorganisms such as E. coli in order to facilitate their capabilities. The cells they enhance are designed for therapeutic applications.
Co-Founder & CEO
At Y Combinator, Startups Manage Molecules Rather Than Code
The top 10 startups from Y Combinator's Demo Day S18 Day 2
Anna Escher, Connie Loizos, Lucas Matney, Jonathan Shieber, Anthony Ha
Documentaries, videos and podcasts
- CompanyA company, abbreviated 'co.', is a legal entity made up of an association of people, be they natural, legal, or a mixture of both, for carrying on a commercial or industrial enterprise.
- Cluster: Synthetic biologyA cluster of topics related to synthetic biology.
- Cluster: BiotechnologyA cluster of topics related to biotechnology.
- Genome engineering
- GenomeEntirety of an organism's hereditary information
- BiomanufacturingBiomanufacturing is a manufacturing process that uses biological systems such as living microorganisms, cultured cells, tissues, enzymes, or in vitro synthetic systems to produce biomolecules used in agriculture, food, material, energy, and pharmaceutical industries.
- BioremediationWaste management technique
- Genetic engineeringDirect manipulation of an organism's genome using biotechnology